SalvaRx Group Plc (LON:SALV) shares reached a new 52-week low on Wednesday . The stock traded as low as GBX 10.20 ($0.13) and last traded at GBX 20 ($0.26), with a volume of 57068 shares traded. The stock had previously closed at GBX 73.50 ($0.96).
Separately, Northland Securities restated a “corporate” rating on shares of SalvaRx Group in a research note on Tuesday, December 11th.
About SalvaRx Group (LON:SALV)
SalvaRx Group plc discovers and develops immune-oncology drugs. The company is based in Ramsey, Isle of Man.
Featured Article: How are the companies in the S&P 500 selected?
Receive News & Ratings for SalvaRx Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SalvaRx Group and related companies with MarketBeat.com's FREE daily email newsletter.